-
flow case studies, Trust and agency services
A biopharmaceutical organic growth story
HUTCHMED’s cutting-edge work helps reduce the toxicity of cancer drugs while increasing their efficacy. flow’s Clarissa Dann finds out how this innovative company is delivering progress for patients and financial self-sufficiency for shareholders
MINUTES min read
You might be interested in
flow case studies, Cash management
Takeda’s in-house banking expansion into APAC Takeda’s in-house banking expansion into APAC
Japanese pharma company Takeda embarked on its in-house banking journey as early as 2008. Assistant Treasurer, Fiona Foley and Treasury Operations Lead for EMEA and Canada, Andreas Schollenberger tell flow’s Desirée Buchholz why the team’s attention is now turning to Asia-Pacific – and how on-behalf-of structures are a big lever for efficiency
flow case studies, Trust and agency services {icon-book}
AstraZeneca and tomorrow’s therapeutics AstraZeneca and tomorrow’s therapeutics
Growing shareholder value and delivering medicines where they are needed most is a tightrope that AstraZeneca has walked for a while. flow’s Clarissa Dann catches up with Andy Barnett, the Anglo-Swedish group’s Head of Investor Relations, about what it takes to maintain investor loyalty over the long term
flow case studies, Cash management, Technology
How BioNTech masters real-time treasury How BioNTech masters real-time treasury
Innovation and speed have been part of BioNTech’s DNA ever since its formation 16 years ago. Back in 2020, it took the German biotech company less than a year to develop a vaccine against Covid-19. flow’s Desirée Buchholz talked to Dirk Schreiber, BioNTech’s Head of Treasury, on why real-time treasury is key for him – and how APIs help to achieve this goal